• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第三代丙型肝炎病毒抗体检测确证试验的性能

Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus.

作者信息

Chaudhary R K, Jacobsen H

机构信息

Laboratory for Viral Hepatitis, Health Canada, Ottawa, Ontario.

出版信息

J Clin Microbiol. 1994 Oct;32(10):2606-8. doi: 10.1128/jcm.32.10.2606-2608.1994.

DOI:10.1128/jcm.32.10.2606-2608.1994
PMID:7529244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC264116/
Abstract

We investigated three immunoblot assays (RIBA 3.0 from Chiron, Matrix from Abbott Laboratories, and LiaTek III from Organon Teknika) for the detection of antibody to hepatitis C virus. RIBA 3.0 and Matrix require reactivity to two antigens and LiaTek III requires reactivity to one for a sample to be positive. We tested 80 samples that were positive in repeat enzyme immunoassays by supplemental tests. The results showed that 55, 46, and 28% were reactive by LiaTek III, RIBA 3.0, and Matrix, respectively; 54, 33, and 13% of the samples were indeterminate by Matrix, RIBA 3.0, and LiaTek III, respectively. There were 32, 21, and 16% nonreactive samples by LiaTek III, RIBA 3.0, and Matrix, respectively. Of the samples positive by RIBA 3.0, only 50 and 76% were reactive by Matrix and LiaTek III, respectively. A large number of samples that were indeterminate by RIBA 3.0 were positive by LiaTek III (52%). The core antigen was the most reactive antigen in all three tests (48 to 57%). The NS4 antigen in Matrix (20%) and LiaTek III (16%) was poorly reactive, although it performed better in RIBA 3.0 (45%). The NS5 and E2/NS1 antigens made minor contributions to reactivity. The combinations of the core, NS3, and NS4 antigens produced 77% of the RIBA 3.0 and 100% of the Matrix reactive samples. The results showed a poor correlation among the three tests.

摘要

我们研究了三种免疫印迹法(Chiron公司的RIBA 3.0、雅培实验室的Matrix以及奥加农泰尼克公司的LiaTek III)用于检测丙型肝炎病毒抗体。RIBA 3.0和Matrix要求样本对两种抗原呈反应性,而LiaTek III要求对一种抗原呈反应性才能判定样本为阳性。我们通过补充检测对80份在重复酶免疫测定中呈阳性的样本进行了测试。结果显示,LiaTek III、RIBA 3.0和Matrix的反应性样本分别为55%、46%和28%;Matrix、RIBA 3.0和LiaTek III的不确定样本分别为54%、33%和13%。LiaTek III、RIBA 3.0和Matrix的无反应性样本分别为32%、21%和16%。在RIBA 3.0呈阳性的样本中,分别只有50%和76%在Matrix和LiaTek III中呈反应性。大量在RIBA 3.0中不确定的样本在LiaTek III中呈阳性(52%)。核心抗原在所有三项检测中反应性最强(48%至57%)。Matrix(20%)和LiaTek III(16%)中的NS4抗原反应性较差,不过在RIBA 3.0中表现较好(45%)。NS5和E2/NS1抗原对反应性的贡献较小。核心、NS3和NS4抗原的组合产生了77%的RIBA 3.0反应性样本和100%的Matrix反应性样本。结果表明这三项检测之间相关性较差。

相似文献

1
Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus.第三代丙型肝炎病毒抗体检测确证试验的性能
J Clin Microbiol. 1994 Oct;32(10):2606-8. doi: 10.1128/jcm.32.10.2606-2608.1994.
2
Confirmation of hepatitis C infection: a comparison of five immunoblot assays.丙型肝炎感染的确认:五种免疫印迹法的比较
Transfusion. 1994 Jul;34(7):603-7. doi: 10.1046/j.1537-2995.1994.34794330015.x.
3
Evaluation of third-generation screening and confirmatory assays for HCV antibodies.丙型肝炎病毒抗体第三代筛查和确证检测方法的评估
Vox Sang. 1994;66(2):122-9. doi: 10.1111/j.1423-0410.1994.tb00293.x.
4
Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.第一代和第二代重组免疫印迹法(RIBA)试剂盒检测丙型肝炎病毒抗体的评估
J Clin Microbiol. 1991 Oct;29(10):2329-30. doi: 10.1128/jcm.29.10.2329-2330.1991.
5
Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.通过第二代重组免疫印迹法对单一抗原呈反应性的献血者的丙型肝炎病毒RNA和肝脏组织学
Hepatology. 1995 Apr;21(4):913-7.
6
Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.使用三种抗丙型肝炎病毒抗体确证试验对经Ortho-HCV RIBA-2检测结果不确定的血清进行分析。
J Clin Microbiol. 1994 Sep;32(9):2071-5. doi: 10.1128/jcm.32.9.2071-2075.1994.
7
Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.埃及癌症患者和献血者体内抗体对丙型肝炎病毒核心抗原和非结构抗原的不同识别模式。
J Clin Microbiol. 1996 Nov;34(11):2665-9. doi: 10.1128/jcm.34.11.2665-2669.1996.
8
E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
J Med Virol. 1994 Dec;44(4):395-7. doi: 10.1002/jmv.1890440415.
9
Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.使用第二代和第三代重组免疫印迹分析及基质对酶免疫分析阳性血清进行补充抗丙型肝炎病毒(HCV)检测,并与HCV-RNA检测进行比较。
Zentralbl Bakteriol. 1998 Oct;288(2):267-75. doi: 10.1016/s0934-8840(98)80049-2.
10
Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems.人类免疫缺陷病毒1型感染者中丙型肝炎病毒抗体流行率:不同检测系统的分析
J Med Virol. 1994 Sep;44(1):49-53. doi: 10.1002/jmv.1890440110.

引用本文的文献

1
Recent advances in laboratory diagnosis of hepatitis C virus infection.丙型肝炎病毒感染实验室诊断的最新进展
Can J Infect Dis. 1994 Nov;5(6):259-62. doi: 10.1155/1994/659467.

本文引用的文献

1
Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples.用于确认丙型肝炎病毒血清学检测结果不确定样本的第三代重组免疫印迹法。
Vox Sang. 1993;64(3):191-2. doi: 10.1111/j.1423-0410.1993.tb05384.x.
2
Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi-antigen assay for hepatitis C virus antibodies.
Transfusion. 1993 Oct;33(10):809-13. doi: 10.1046/j.1537-2995.1993.331094054616.x.
3
Improved detection of antibodies to hepatitis C virus by use of a new recombinant immunoblot assay.
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):398-400. doi: 10.1007/BF01964444.
4
Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
Am J Clin Pathol. 1993 Jun;99(6):702-4. doi: 10.1093/ajcp/99.6.702.
5
Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction.采用重组免疫印迹法、合成免疫印迹法和聚合酶链反应检测丙型肝炎病毒感染。
J Clin Lab Anal. 1993;7(3):164-7. doi: 10.1002/jcla.1860070306.
6
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.不同人群中丙型肝炎病毒(HCV)抗体阳性者的HCV病毒血症患病率及其意义。
J Clin Microbiol. 1993 May;31(5):1189-93. doi: 10.1128/jcm.31.5.1189-1193.1993.
7
Evaluation of laboratory assays for screening antibody to hepatitis C virus.丙型肝炎病毒抗体筛查实验室检测方法的评估
Transfusion. 1993 Mar;33(3):268-70. doi: 10.1046/j.1537-2995.1993.33393174455.x.
8
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.前瞻性随访的急性和慢性非甲非乙型肝炎输血受者中丙型肝炎病毒抗体的检测
N Engl J Med. 1989 Nov 30;321(22):1494-500. doi: 10.1056/NEJM198911303212202.
9
Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.第一代和第二代重组免疫印迹法(RIBA)试剂盒检测丙型肝炎病毒抗体的评估
J Clin Microbiol. 1991 Oct;29(10):2329-30. doi: 10.1128/jcm.29.10.2329-2330.1991.
10
Diagnosis of hepatitis C. Facts and perspectives.丙型肝炎的诊断。事实与展望。
J Hepatol. 1991 May;12(3):279-82. doi: 10.1016/0168-8278(91)90827-x.